News

iCo Therapeutics said that iCo-007 is designed and discovered by ISIS Pharmaceuticals, iCo-007 is a second-generation antisense drug targeting c-Raf kinase for the treatment of DME and diabetic

Sanofi-aventis said that Lovenox, by nature, is a complex biological product and its efficacy and safety profile relies on the strict adherence to the specific processes applied in

The anti-PTH antibody forms the basis of an existing relationship between AbD Serotec and a diagnostic company which markets clinical parathyroid hormone assays. PTH is the regulator of

MedImmune expects to provide approximately 15 million doses of its trivalent (three-strain) nasal spray flu vaccine through a variety of private health care practices, public health departments, school-located

Boston Scientific said that EZ Stent System is an intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. Neuroform EZ Stent

Emisphere said that an independent Data Monitoring Committee (DMC) conducted a futility analysis of one-year data for all patients enrolled in this two-year study, including assessments of safety

Telmisartan is an angiotensin II receptor blocker (ARB) and amlodipine besylate, a calcium channel blocker (CCB). Nippon Boehringer and Astellas said that the Micamlo combination tablets AP is

Eisai said that Aricept 23mg tablet offers dosing option for patients with moderate-to-severe AD for whom few treatments are available. Aricept 23mg tablet has received approval based on

The CAPRA-1 study of Lodotra assessed 288 patients with active RA in a 12-week, randomised, double-blind, placebo-controlled trial comparing bedtime administration of Lodotra with morning administration of immediate